| |
| |
|
| Insider
Information: |
Young Richard A |
| Relationship: |
Director |
| City: |
Bridgewater |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
808,186 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,108,426 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
808,186 |
|
|
| Total
Value |
$2,108,426 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Enzon Pharmaceuticals Inc |
ENZN |
Director |
2012-07-02 |
30,231 |
2010-04-19 |
0 |
Premium* |
|
|
Syros Pharmaceuticals, Inc. |
SYRS |
Director |
2023-09-16 |
38,837 |
|
0 |
Premium* |
|
|
Omega Therapeutics, Inc. |
OMGA |
Director |
2023-06-02 |
739,118 |
2022-09-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2023-09-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,666 |
38,837 |
0 |
- |
|
| OMGA |
Omega Therapeutics, Inc. |
Director |
– • – |
2023-06-02 |
4 |
AS |
$8.00 |
$40,000 |
D/D |
(5,000) |
739,118 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
36,171 |
0 |
- |
|
| OMGA |
Omega Therapeutics, Inc. |
Director |
– • – |
2023-05-01 |
4 |
AS |
$8.00 |
$40,000 |
D/D |
(5,000) |
744,118 |
0 |
% |
|
| OMGA |
Omega Therapeutics, Inc. |
Director |
– • – |
2023-04-06 |
4 |
AS |
$8.00 |
$40,000 |
D/D |
(5,000) |
749,118 |
0 |
% |
|
| OMGA |
Omega Therapeutics, Inc. |
Director |
– • – |
2023-03-17 |
4 |
AS |
$8.00 |
$80,000 |
D/D |
(10,000) |
754,118 |
0 |
% |
|
| OMGA |
Omega Therapeutics, Inc. |
Director |
– • – |
2023-01-10 |
4 |
AS |
$8.00 |
$160,000 |
D/D |
(20,000) |
764,118 |
0 |
% |
|
| OMGA |
Omega Therapeutics, Inc. |
Director |
– • – |
2022-09-14 |
4 |
AS |
$8.00 |
$80,000 |
D/D |
(10,000) |
784,118 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2021-02-16 |
4 |
AS |
$12.05 |
$45,188 |
D/D |
(3,750) |
321,711 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2021-02-08 |
4 |
AS |
$13.04 |
$48,900 |
D/D |
(3,750) |
325,461 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2020-11-17 |
4/A |
AS |
$8.75 |
$46,874 |
D/D |
(5,357) |
329,211 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2020-11-17 |
4 |
AS |
$8.75 |
$46,874 |
D/D |
(5,357) |
339,211 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2020-11-16 |
4/A |
AS |
$8.98 |
$5,684 |
D/D |
(633) |
334,568 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2020-11-16 |
4 |
AS |
$8.98 |
$5,684 |
D/D |
(633) |
344,568 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2020-10-19 |
4 |
AS |
$8.75 |
$49,639 |
D/D |
(5,673) |
335,201 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2020-10-15 |
4 |
AS |
$8.75 |
$2,774 |
D/D |
(317) |
340,874 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2020-09-15 |
4 |
AS |
$10.39 |
$62,236 |
D/D |
(5,990) |
341,191 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2020-08-17 |
4 |
AS |
$12.59 |
$75,414 |
D/D |
(5,990) |
347,181 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2020-07-15 |
4 |
AS |
$11.85 |
$70,982 |
D/D |
(5,990) |
353,171 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2020-06-15 |
4 |
AS |
$8.75 |
$52,413 |
D/D |
(5,990) |
359,161 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2020-05-15 |
4 |
AS |
$9.22 |
$55,242 |
D/D |
(5,990) |
365,151 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2020-04-15 |
4 |
AS |
$8.75 |
$209,650 |
D/D |
(23,960) |
371,141 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2019-08-16 |
4 |
AS |
$10.00 |
$227,000 |
D/D |
(22,700) |
395,101 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2019-08-15 |
4 |
AS |
$10.00 |
$23,000 |
D/D |
(2,300) |
417,801 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2017-08-14 |
4 |
AS |
$22.00 |
$72,204 |
D/D |
(3,282) |
420,101 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
